These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 17143357

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP.
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH, Wang J, Chen C.
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [Abstract] [Full Text] [Related]

  • 10. Double phototherapy in jaundiced term infants with hemolysis.
    Thaithumyanon P, Visutiratmanee C.
    J Med Assoc Thai; 2002 Nov; 85(11):1176-81. PubMed ID: 12546314
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial.
    Girish G, Chawla D, Agarwal R, Paul VK, Deorari AK.
    Indian Pediatr; 2008 Aug; 45(8):653-9. PubMed ID: 18723908
    [Abstract] [Full Text] [Related]

  • 12. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
    Sarici SU, Alpay F, Yeşilkaya E, Ozcan O, Gökçay E.
    Turk J Pediatr; 2002 Aug; 44(3):248-50. PubMed ID: 12405439
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU, Yurdakök M, Serdar MA, Oran O, Erdem G, Tekinalp G, Yiğit S.
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A, Elzaabi M, Waegemans T, Roch B, Aujard Y.
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM, Lenarsky C, Oakes RC, Reiff MI.
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.